Cellbxhealth (LON:CLBX) Posts Earnings Results

Cellbxhealth (LON:CLBX) issued its quarterly earnings data on Wednesday. The company reported GBX (0.24) earnings per share for the quarter, Digital Look Earnings reports.

Cellbxhealth Stock Performance

Shares of LON:CLBX opened at GBX 1.39 on Thursday. The stock has a market capitalization of £15.74 million and a PE ratio of -0.25. Cellbxhealth has a 52-week low of GBX 0.85 and a 52-week high of GBX 2.70.

Cellbxhealth Company Profile

CelLBxHealth plc is a precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis – including whole-cell imaging, proteomic profiling and full genomic workflows.
Commercial activities centre on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs and clinical lab partnerships.